CHARLES RIVER LABORATORIES INTERNA (CRL)
NYSE • Healthcare
Last close at July 21, 2026 at 20:00 UTC
Fundamentals Charts
About CHARLES RIVER LABORATORIES INTERNA
Charles River Laboratories International, Inc. is a healthcare research-services company listed on the NYSE under CRL that supports pharmaceutical and biotechnology customers across preclinical drug development, laboratory testing, and research model supply. Its operations produced $4.0 billion of revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
CHARLES RIVER LABORATORIES INTERNA's Technical Indicators Summary
CRL registers a neutral technical profile as stronger trend readings coexist with mixed price placement versus moving averages. ADX in the low 30s indicates underlying trend strength, yet the market trades below short- and medium-term averages while comfortably above long-term averages, producing conflicting signals. Momentum indicators are muted—RSI near neutral and negative short-term momentum—while on-balance volume is positive and volatility is moderate with an ATR near 4%. The pivot sits above the current price, adding near-term resistance. Technical takeaway: Neutral—trend strength balanced by short-term moving-average resistance.
| Indicator | Value |
|---|---|
RSI (14) | 53.66 |
Stochastic %K (14, 3, 3) | 38.95 |
CCI (20) | -11.79 |
WPR (14) | -93.45 |
Momentum (10) | -13.68 |
MFI | 48.55 |
MACD Level (12, 26) | 9.68 |
Bollinger Bands | $191.33 - $250.91 |
ATR (14) | $8.35 (3.84%) |
ADX (14) | 32.79 |
OBV | 10,675,413 |
Classic Pivot Point | $225.18 |
Fibonacci Pivot Point | $225.18 |
Exponential Moving Averages | $184.11 - $225.11(5 indicators) |
Simple Moving Averages | $181.54 - $228.01(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The session ended with CRL modestly under yesterday’s close, a tiny -0.14% gap. The session closed with mild sector strength (0.63%), slightly supporting risk appetite. Investors weigh CRL's earnings trajectory amid stronger outsourcing demand.
Trading Volume
Below 10d avg (841.0K)
832.8K
vs S&P 500 Today
Underperforming Market
-1.04%
52-Week Position
Upper range
80.3%
Updated: July 21, 2026 at 20:38 UTC
Quote Summary
CRL Headlines
Citi Resets Life Sciences And MedTech Views
March 11, 2026